	Educational, Racial, and Geographic Inequalities in Breast Cancer Screening and Diagnosis among Brazilian Women. J Racial Ethn Health Disparities Santana FG, de Branco FMS, Cunha KS, Rezende LFM, Azeredo CM. PMID: 42446866 [PubMed - as supplied by publisher]
	Real-world clinical outcomes of intermediate-risk PAM50 (i-ROR) in HR+/HER2- early breast cancer and eligibility for adjuvant CDK4/6 inhibitors. Breast Cancer Res Treat Terán S, Illia M, Quevedo MC, Moreno ML, Bianchi MA, Lema L, González C, Tolosa P, Madariaga A, Manso L, Ruano Y, Parrilla L, Cobos MÁ, Ciruelos E, Sánchez-Bayona R. PMID: 42446834 [PubMed - indexed for MEDLINE]
	lncRNA MEG3 and Beclin-1 as diagnostic biomarkers in serous ovarian carcinoma: molecular and immunohistochemical insights. J Mol Histol El Desoky AMZ, Abdelgeleel HM, Moustafa M, Abdalrahman MAM, Eldaly MM. PMID: 42446766 [PubMed - indexed for MEDLINE]
	Advances in quercetin-based therapeutics for breast cancer: natural, synthetic, and nanotechnology-driven approaches. Med Chem Res Shagufta, Ahmad I, Bazbouz LZ, Eissa AW, Abdellatif S. PMID: 42446692 [PubMed - indexed for MEDLINE]
	Automation Bias in Action: Eye Tracking of Humans Reading Screening Mammograms with and without AI Prompts. Radiology Taib AG, Partridge GJW, Phillips P, Maxwell-Armstrong C, Chen X, Hofvind SSH, James JJ, Chen Y. PMID: 42446361 [PubMed - indexed for MEDLINE]
	The Dual Role of TLR2 in Breast Cancer: Implications for Therapeutic Targeting. Immunol Invest Yu H, Zhang Y, Du T, Zuo S. PMID: 42446204 [PubMed - as supplied by publisher]
	The Evolving Landscape of Deep Learning in Breast Cancer Imaging: A Bibliometric Study of Segmentation, Detection, and Diagnostic Research From 2006 to 2025. Cancer Control Zeng S, Wang L, Zhang Y, Deng Y, Shen X, Li Y. PMID: 42446135 [PubMed - indexed for MEDLINE]
	Gene expression profiling of ovarian cancer reveals candidate diagnostic and prognostic biomarkers: An integrated bioinformatics approach. Cancer Biomark Woode M, Appah MA, Alhassan EK, Makwo T, Asante DB, Agyirifo DS. PMID: 42445957 [PubMed - indexed for MEDLINE]
	Baculoviral Inhibitor of Apoptosis Repeat Containing 5 (BIRC5) Regulates Cancer Stem Cell Properties and Epithelial-Mesenchymal Transition in Human Breast Cancer Cells. Dev Reprod Jang JY, Kim RK. PMID: 42445845 [PubMed]
	A Preliminary Comparative Study on Clinical and Pathologic Response Patterns of Breast Cancer in Ghanaian Women Undergoing Neoadjuvant Chemotherapy and Hormonal Therapy. J West Afr Coll Surg Awoonor-Williams R, Abaidoo CS, Adjei E, Kyei I, Aitpillah F, Boakye E, Amankwaa-Frempong E, Yorke J, Darko ND, Diby TK, Boakye RA, Tetteh J, Appiah AK, Atobiga CN, Adjei-Antwi C, Nketsiah J, Sarkodie FK, Boakye-Yiadom J, Ansah EO. PMID: 42445763 [PubMed]
	Precision Endocrine-Based Combinations After CDK4/6 Inhibitor Progression in HR-Positive Metastatic Breast Cancer. Drug Des Devel Ther Abdel-Razeq H. PMID: 42445743 [PubMed - indexed for MEDLINE]
	Review of ctDNA in breast cancer - present utility and future perspectives. Rep Pract Oncol Radiother Suryavanshi M, Razdan S, Kumar M. PMID: 42445712 [PubMed]
	Factors Affecting Pap Smear Screening Among Women of Reproductive Age in Owerri West LGA, Imo State, South-Eastern Nigeria. J Prev Med Hyg Dozie UW, Favour Chisom N, Nwokorie MA, Dozie KCN, Nwaokoro CJ, Chukwuocha UM, Ekeleme UG, Iwuala CC, Okereke CC, Diala IM, Raphael CO, Dozie INS. PMID: 42445592 [PubMed - indexed for MEDLINE]
	Ferroptosis Signature Correlates with Ovarian Cancer Prognosis and Chemotherapy Response. Int J Gen Med Zhang Y, Jiang Q, Yu M, Lin C. PMID: 42445556 [PubMed]
	A LASSO-based nomogram for predicting breast cancer-specific survival in elderly patients after surgery: a large retrospective cohort study. Transl Cancer Res Wang Z, Zhang H, Li Q. PMID: 42445437 [PubMed]
	Recombinant adeno-associated virus-mediated HSV-TK/GCV gene therapy for ovarian cancer: an experimental study. Transl Cancer Res Xiong Y, Zhou W, Yang J, Li Y, Shen Y, Lv Y, Meng C. PMID: 42445418 [PubMed]
	Development and validation of a DYX1C1- and GNAI1-based nomogram for predicting relapse in HER2-positive breast cancer treated with trastuzumab. Transl Cancer Res Liu J, Li X, Li Z, Zhang R, Zhang Y, Zhang W, He J, Zhang H. PMID: 42445417 [PubMed]
	Development and validation of an interpretable model based on ultrasound radiomics for predicting Ki-67 expression levels in breast cancer. Transl Cancer Res Zhang C, Zheng Y, Fang C, Huang Y, Liu J. PMID: 42445392 [PubMed]
	Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study. Int J Womens Health Deng J, Cheng L, Xiang G, Yang Z, Li C, He Y, Chen X. PMID: 42445369 [PubMed]
	Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies. Ther Clin Risk Manag Deng QC, Kuang WB, Yang YJ, Gong CP, Zhang YP, Luo Q, Luo LP, Wang GM. PMID: 42445280 [PubMed]

Articles 1 - 20 / 332110

Page 1 of 16606



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy